|
🐜
|
Immune dysregulation in cancer patients developing immune-related adverse events
11 auth.
Shaheen Khan,
S. Khan,
Xin Luo,
Farjana J Fattah,
Jessica M. Saltarski,
Yvonne Gloria-McCutchen,
...
Rong Lu,
Yang Xie,
Quanzhen Li,
E. Wakeland,
D. Gerber
|
7 |
2018 |
7
🐜
|
|
🐜
|
SIRT1/PGC-1α/PPAR-γ Correlate With Hypoxia-Induced Chemoresistance in Non-Small Cell Lung Cancer
7 auth.
R. Xu,
Xin Luo,
Xuan Ye,
Huan Li,
Hongyue Liu,
Qiong Du,
...
Qing Zhai
|
5 |
2021 |
5
🐜
|
|
🦁
|
Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer
Xin Luo,
Jing Xu,
Jianhua Yu,
P. Yi
|
4 |
2021 |
4
🦁
|
|
🐬
|
Immune cell infiltration-associated signature in colon cancer and its prognostic implications
D. Deng,
Xin Luo,
Sifang Zhang,
Zhijie Xu
|
3 |
2021 |
3
🐬
|
|
🐬
|
Effect of CO2 pneumoperitoneum on the proliferation of human ovarian cancer cell line SKOV-3 and the expression of NM23-H1 and MMP-2
Ying Zhang,
Xin Luo,
Bing-jie Fan,
Huijuan Chen,
Aizhen Fu,
Jinzhi Huang
|
3 |
2015 |
3
🐬
|
|
🐜
|
Pharmacoeconomic evaluations of CDK4/6 inhibitors plus endocrine therapy for advanced hormone receptor-positive (HR+) and human epidermal growth factor receptor-2 negative (HER2−) breast cancer: a systematic review
7 auth.
Linhui Zhu,
Mengmeng Wang,
Xin Luo,
Huan Li,
Han Shan,
Qiong Du,
...
Qing Zhai
|
3 |
2021 |
3
🐜
|
|
🦁
|
Metastases of transverse colon cancer to bilateral ovaries (Krukenberg tumor) and the left breast: A case report
Xin Luo,
Jue Wang,
Jia Zhao,
Rui Chen,
X. Zha
|
3 |
2017 |
3
🦁
|
|
🦁
|
Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis
8 auth.
Xin Luo,
Bo Yu,
Nanchun Jiang,
Qiong Du,
Xuan Ye,
Huan Li,
...
Wen-quan Wang,
Qing Zhai
|
2 |
2020 |
2
🦁
|
